India's Gennova works on specific vaccine to target Omicron COVID-19.

M2 EQUITYBITES-January 17, 2022-India's Gennova works on specific vaccine to target Omicron COVID-19

(C)2022 M2 COMMUNICATIONS http://www.m2.com

Indian biotechnology company Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or two, Reuters news agency reported on Monday, citing a source with direct knowledge of the matter.

According to the source, who did not want to be named as the information was private, said the product might need a small trial in India...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT